首页 | 本学科首页   官方微博 | 高级检索  
     


Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study
Authors:Virginie Nerich PharmD  PhD  Christophe Guyeux PhD  Michel Henry-Amar MD  PhD  Raphaël Couturier PhD  Catherine Thieblemont MD  PhD  Vincent Ribrag MD  PhD  Hervé Tilly MD  PhD  Corinne Haioun MD  PhD  René-Olivier Casasnovas MD  PhD  Franck Morschhauser MD  PhD  Pierre Feugier MD  PhD  David Sibon MD  PhD  Loic Ysebaert MD  PhD  Emmanuelle Nicolas-Virelizier MD  PhD  Florence Broussais-Guillaumot MD  Gandhi L. Damaj MD  PhD  Jean-Philippe Jais MD  PhD  Gilles Salles MD  PhD  Macha Woronoff-Lemsi PharmD  PhD  Nicolas Mounier MD  PhD
Affiliation:1. Department of Pharmacy, University Hospital, Besançon, France;2. Femto-ST Institute, UMR 6174 CNRS, University of Bourgogne Franche-Comté, Besançon, France;3. French Center on eHealth, North-West Region Data Processing Center and French National League Against Cancer Clinical Research Platform, CCC François Baclesse, Caen, France;4. Hemato-Oncology Unit, Saint-Louis University Hospital Center, Public Hospital Network of Paris, Paris, France;5. Hematology Unit, Gustave Roussy Cancer Campus, Villejuif, France;6. Hematology Department and French Institute of Health and Medical Research Unit 1243, Henri Becquerel Center, Rouen, France;7. Lymphoid Malignancies Unit, Henri Mondor University Hospital Center, Public Hospital Network of Paris, Créteil, France;8. Hematology Unit and French Institute of Health and Medical Research Unit 1231, Bocage Hospital, Dijon Bourgogne Regional University Hospital Center, Dijon, France;9. Hematology Transfusion Institute, Claude Huriez Hospital, Lille Regional University Hospital Center, Lille, France;10. Hematology Unit, Brabois Hospital, Nancy University Hospital Center, Vandoeuvre-lès-Nancy, France;11. Hematology Unit, Necker University Hospital for Sick Children, Public Hospital Network of Paris, Paris, France;12. Oncopole, Toulouse University Cancer Institute, Toulouse, France;13. Hematology Unit, Léon Bérard Center, Lyon, France;14. Clinical Research Department–Lymphoma Study Association, Lyon South Hospital Center, Pierre-Bénite, France;15. Basse-Normandy Hematology Institute, Côte de Nacre Regional University Hospital Center, Caen, France;16. Laboratory of Biostatistics, Paris V University–Descartes, Paris, France;17. Faculty of Medicine, Claude Bernard University, Lyon, France;18. INSERM, EFS-BFC, UMR1098, University of Franche-Comté, Besançon, France

Department of Clinical Research and Innovation, University Hospital, Besançon, France;19. Onco-Hematology Unit, l'Archet Hospital, Nice University Hospital Center, University of Côte d'Azur, Nice, France

Abstract:
Keywords:cancer survivors  explanatory factors  health care cost  health care resource use  non-Hodgkin lymphoma  rituximab
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号